Literature DB >> 17996735

Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis.

Karim Chahed1, Maria Kabbage, Bechr Hamrita, Christelle Lemaitre Guillier, Mounir Trimeche, Sami Remadi, Laurence Ehret-Sabatier, Lotfi Chouchane.   

Abstract

BACKGROUND: Little emphasis has been placed today on the elucidation of protein alterations in male breast carcinogenesis.
METHODS: Protein extracts were subjected to both isoelectric focusing (IEF) and non-equilibrium pH gradient electrophoretic (NEPHGE) analyses. Differentially expressed proteins in tumor tissues were identified by matrix assisted laser desorption /ionization time of flight (MALDI-TOF) mass spectrometry and database search.
RESULTS: Some of the alterations involve variations in the expression of cytokeratins 8, 18 and 19. More interestingly, tropomyosin1, a protein known to play a role in suppression of the malignant phenotype, was found to be under-expressed in cancer tissues, implicating a possible pivotal role for this protein in male breast carcinogenesis. Co-upregulation of molecular chaperones (heat shock protein HSP27 and protein disulfide isomerase), stress related proteins (peroxiredoxin 1 and peptidylprolyl isomerase A) and glycolytic enzymes (enolase 1) occurred also in male breast tumors. Some of the remaining alterations include proteins involved in invasion and metastasis, such as galectin 1 and cathepsin D.
CONCLUSIONS: The present study represents a first proteomic investigation of protein alterations in infiltrating ductal carcinomas (IDCA) of the male breast. A number of protein alterations in tumor tissues have been characterised thus, providing new insights into the molecular mechanisms underlying this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996735     DOI: 10.1016/j.cca.2007.10.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Serum Proteomic Signatures of Male Breast Cancer.

Authors:  Eleni Zografos; Athanasios K Anagnostopoulos; Aggeliki Papadopoulou; Evangelia Legaki; Flora Zagouri; Evangelos Marinos; George T Tsangaris; Maria Gazouli
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

3.  Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patients.

Authors:  Wala Ben Kridis-Rejeb; Dorra Ben Ayed-Guerfali; Nihel Ammous-Boukhris; Wajdi Ayadi; Chamseddine Kifagi; Slim Charfi; Ines Saguem; Tahia Sellami-Boudawara; Jamel Daoud; Afef Khanfir; Raja Mokdad-Gargouri
Journal:  Mol Biol Rep       Date:  2020-09-08       Impact factor: 2.316

4.  High-throughput Proteomic Profiling of Male Breast Cancer Tissue.

Authors:  Eleni Zografos; Stavros C Proikakis; Athanasios K Anagnostopoulos; Anna-Maria Korakiti; Flora Zagouri; Maria Gazouli; George T Tsangaris
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

5.  Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.

Authors:  Pavel Gromov; Irina Gromova; Jakob Bunkenborg; Teresa Cabezon; José M A Moreira; Vera Timmermans-Wielenga; Peter Roepstorff; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2009-11-23       Impact factor: 6.603

6.  The differential expression of aqueous soluble proteins in breast normal and cancerous tissues in relation to stage and grade of patients.

Authors:  Seng Liang; Manjit Singh; Lay-Harn Gam
Journal:  J Biomed Biotechnol       Date:  2010-12-09

Review 7.  Roles of Protein Disulfide Isomerase in Breast Cancer.

Authors:  Suhui Yang; Chanel Jackson; Eduard Karapetyan; Pranabananda Dutta; Dulcie Kermah; Yong Wu; Yanyuan Wu; John Schloss; Jaydutt V Vadgama
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.